IHCH-3064

Cat. No.: IBDI-435386

IHCH-3064 is a dual-acting compounds targeting Adenosine A2A?Receptor and HDAC. IHCH-3064 exhibits potent binding to A2AR (Ki=2.2 nM) and selective inhibition of HDAC1 (IC50=80.2 nM), with good antiproliferative activity against tumor cell lines in vitro.?IHCH-3064 is a tumor immunotherapeutic agent.

Product Details

Target	Adenosine Receptor | HDAC
Molecular Weight	479.49
SMILES	O=C(C1=CC=C(CCN2N=CC3=C2N=C(N)N4N=C(C5=CC=CO5)N=C34)C=C1)NC6=C(N)C=CC=C6

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.